Would not be surprised if Merck is watching Vivos Inc closely as a top Biotech company with an Animal Health and Human Oncology divisions. Be nothing for them to drop $3 to 5B to acquire Vivos Inc. Companies like Vivos Inc become their R&D arm with large sums of money budgeted every year to acquire new technologies.
News 
Market Data 
Discover 
